• Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • You are here:
  • Home
  • Insights
  • New SCCS Guidance on Nanomaterials in Cosmetics: Ensuring Safety and EU CPR Compliance

New SCCS Guidance on Nanomaterials in Cosmetics: Ensuring Safety and EU CPR Compliance

Recent advances in Nanotechnology have opened new opportunities for innovation in cosmetics. In Europe, the use of Nanomaterials (NM) in cosmetics is regulated under the Cosmetic Regulation (EC) No 1223/2009 (CPR). When the CPR
was adopted in 2009, there was no internationally agreed definition of NM. Consequently, the CPR provided a sector-specific definition of NM in Article 2(1)(k), which slightly deviates from the first Commission Recommendation issued in
2011 regarding the particle size distribution thresholds and the concept of natural, incidental or engineered NM.
The EU Scientific Committee on Consumer Safety (SCCS) requires a thorough risk assessment for demonstrating the safety of NM uses in cosmetics. Its recommendations and criteria evolved over time, key elements being the 2017 checklist
for the use NM in cosmetics (SCCS/1588/17) and the 2nd revision of the SCCS guidance on the safety assessment of NM in cosmetics in 2023 (SCCS/1655/23) which should be considered alongside with the latest revision of the SCCS Notes of
Guidance (SCCS/1647/22). Revised guidance SCCS/1655/23 includes new sections (e.g., solubility/dissolution rate, aspect ratio, uptake into blood cells, endcorine disruption), provides a comprehensive overview of the key aspects triggering
potential safety concerns and a revision of section on read-across/grouping. It emphasises the importance of apprpriate characterisation of NM and the submission of a relevant data set considering the specific properties of NM.

READ MORE ON THE PDF

More insights

Advancing cosmetic safety: An industry case study using an NGRA framework to support the safety of daidzein in a cosmetic product

Previous thumb

New Approach Methodologies (NAMs) For Prostaglandin Safety In Cosmetics

Next thumb
Scroll

 

ToxMinds are specialised in ensuring product safety and compliance.

We are passionate about toxicology and how emerging scientific developments can be utilised to support our customers in bringing safe, regulatory compliant and sustainable products to the marketplace.

 

 

 

 

Belgium
ToxMinds BV
Avenue de Tervueren 188A, bte 12
B-1150 Brussels Belgium

VAT BE 0877.628.383

Tel: +32 (0)2 762 9145
Email: contact us

 

 

 

 

India
ToxMinds India Consulting Pvt. Ltd.
Unit 305, 3rd Floor, Brigade IRV Centre, Whitefield, Bangalore-560066, India

 

Tel: +91 804 204 19 20
Email: contact us

 

 

 

 

 

LinkedIN
Copyright and disclaimer | Data privacy
  • Home
  • Industries
  • Services
  • Team
  • Insights
  • Careers
  • Contact
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok